<?xml version='1.0' encoding='utf-8'?>
<document id="26891697"><sentence text="Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: a prospective cross-sectional study."><entity charOffset="14-25" id="DDI-PubMed.26891697.s1.e0" text="ceftriaxone" /></sentence><sentence text="Ceftriaxone is one of the most commonly used antibiotics due to its high antibacterial potency, wide spectrum of activity and low potential for toxicity"><entity charOffset="0-11" id="DDI-PubMed.26891697.s2.e0" text="Ceftriaxone" /></sentence><sentence text=" However, the global trend shows misuse of this drug" /><sentence text=" The aim of this study was to evaluate prospectively the appropriateness of ceftriaxone use in medical and emergency wards of Tikur Anbessa Specialized Hospital"><entity charOffset="76-87" id="DDI-PubMed.26891697.s4.e0" text="ceftriaxone" /></sentence><sentence text="" /><sentence text="A prospective cross-sectional study was conducted by reviewing medication records of patients receiving ceftriaxone during hospitalization at Tikur Anbessa Specialized Hospital between February 1 and June 30, 2014"><entity charOffset="104-115" id="DDI-PubMed.26891697.s6.e0" text="ceftriaxone" /></sentence><sentence text=" Drug use evaluation was conducted to determine whether ceftriaxone was being used appropriately based on six criteria namely indication for use, dose, frequency of administration, duration of treatment, drug-drug interaction, culture and sensitivity test"><entity charOffset="56-67" id="DDI-PubMed.26891697.s7.e0" text="ceftriaxone" /></sentence><sentence text=" The evaluation was made as per the protocol developed from current treatment guidelines" /><sentence text="" /><sentence text="The total of 314 records of patients receiving ceftriaxone was reviewed"><entity charOffset="47-58" id="DDI-PubMed.26891697.s10.e0" text="ceftriaxone" /></sentence><sentence text=" The prescribing rate of ceftriaxone was found to be very high (58 % point prevalence)"><entity charOffset="25-36" id="DDI-PubMed.26891697.s11.e0" text="ceftriaxone" /></sentence><sentence text=" Ceftriaxone use was empiric in 274 (87"><entity charOffset="1-12" id="DDI-PubMed.26891697.s12.e0" text="Ceftriaxone" /></sentence><sentence text="3 %) cases" /><sentence text=" The most common indication for ceftriaxone use was pneumonia; observed in 110 (35"><entity charOffset="32-43" id="DDI-PubMed.26891697.s14.e0" text="ceftriaxone" /></sentence><sentence text="0 %) cases" /><sentence text=" The most common daily dosage, frequency of administration and duration of treatment with ceftriaxone were 2 g (88"><entity charOffset="90-101" id="DDI-PubMed.26891697.s16.e0" text="ceftriaxone" /></sentence><sentence text="9 %), twice-daily (98" /><sentence text="4 %) and 8-14 days (46" /><sentence text="2 %), respectively" /><sentence text=" Inappropriate use of ceftriaxone was observed in most of cases (87"><entity charOffset="22-33" id="DDI-PubMed.26891697.s20.e0" text="ceftriaxone" /></sentence><sentence text="9 %), the greatest proportion of which was attributed to inappropriate frequency of administration (80" /><sentence text="3 %), followed by absence of culture and sensitivity test (53" /><sentence text="2 %)" /><sentence text="" /><sentence text="This study revealed that the inappropriate use of ceftriaxone was very high in the medical and emergency wards of Tikur Anbessa Specialized Hospital"><entity charOffset="50-61" id="DDI-PubMed.26891697.s25.e0" text="ceftriaxone" /></sentence><sentence text=" This may lead to emergence of resistant pathogens which in turn lead to treatment failure and increased cost of therapy" /><sentence text=" Therefore, adherence to current evidence-based guidelines is recommended" /><sentence text="" /></document>